Starting next year, Oslo Cancer Cluster will co-power the conference E-health in Norway (EHiN).
– This is a natural continuation of the work we do in digitalisation, for a better understanding of cancer and better patient treatment, said Ketil Widerberg, General Manager of Oslo Cancer Cluster, at this year’s conference.
The Norwegian Ministry of Health and Care Services (HOD) and ICT Norway started a collaboration on creating a national meeting place for e-health. ICT Norway launched the first EHiN conference five years ago. Oslo Cancer Cluster is happy to announce that we are now one of the three stakeholders in this yearly conference, together with ICT Norway and Macsimum.
EHiN 2018 took place in Oslo Spektrum and was the biggest meeting place for actors in the public and private sector working with e-health in Norway. The conference had 150 speakers and 1300 participants. EHiN 2019 will be the 6th year of the conference.
— EHiN is an important meeting place for public and private actors, and for academia and business. This is a natural prolongation of the many meeting places Oslo Cancer Cluster is always working to establish and preserve, Ketil Widerberg says.
Digital technologies are part of what drives innovation to the maximum benefit of cancer patients. Widerberg is certain that e-health will change the way we understand and treat cancer in the future.
– E-health is part of the matrix for how we give the right medicine to the right patient at the right time, meaning precision medicine. One example of what we specifically do in this area, is a recent project we have been part of, called PERMIDES.
An e-health success story
From August 2016 until August 2018, Oslo Cancer Cluster together with five other European clusters in medicine and ICT, was managing a Horizon 2020 EU project called PERMIDES. It is a European e-health success story in bringing together biopharma and IT sectors.
D.B.R.K Gupta Udatha is Director (Digital and EU) at Oslo Cancer Cluster. He has been instrumental in PERMIDES and explains why the project has had such a positive effect on the small and medium sized enterprises (SMEs) it has worked with.
— PERMIDES was a project to anchorage digital transformation across SMEs in biotechnology and pharmaceuticals. We aimed to see where the biopharma companies were lacking digital infrastructure and where the ICT companies could bring digital skills to make sure that the biopharma companies were up to date, Dr. Udatha said at this year’s EHiN.
The project created matchmaking opportunities between these two different categories of companies and was awarded EUR 4.8 million from the EU’s Horizon2020 programme. It addressed specific challenges for SMEs to go digital with a precision medicine product.
Read more bout the PERMIDES project here.